Involvement of tissue kallikrein but not plasma kallikrein in the development of symptoms mediated by endogenous kinins in acute pancreatitis in rats

British Journal of Pharmacology

Volumn 137, Issue 5, 2002, Pages 692-700

  Griesbacher, Thomas ^a   Rainer, Irmgard ^a   Tiran, Beate ^a   Evans, D Michael ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

FE999024; FE999026; Inflammation; Kallikrein inhibitors; Pancreatitis; Plasma kallikrein; Tissue kallikrein

Indexed keywords

2 [2' AMINO 3' (4' CHLOROPHENYL)PROPANOYLAMINO] N (3 GUANIDINOPROPYL) 3 (1 NAPHTHYL)PROPANOAMIDE; 4 [2' [2'' (CARBOXYMETHYLAMINO) 3'' CYCLOHEXYLPROPANOYLAMINO] 3' PHENYLPROPANOYLAMINO]PIPERIDINE 1 CARBOXAMIDINE; CERULETIDE; CH 2856; CH 4215; FE 999024; FE 999026; KININ; PLASMA KALLIKREIN; PLASMA PROTEIN; TISSUE KALLIKREIN; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EDEMA; ENZYME ACTIVITY; FEMALE; HEMOCONCENTRATION; HYPOVOLEMIA; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT;

ACUTE DISEASE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; KININS; PANCREATITIS; PEPTIDES; PLASMA KALLIKREIN; RATS; RATS, SPRAGUE-DAWLEY; TISSUE KALLIKREINS;

EID: 0036848045     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704910     Document Type: Article

References (31)

1. Allen, T.H. & Orahovats, P.D. (1948). Spectrophotometric measurements of traces of the dye T-1824 by extraction with cellophane from blood serum and urine of normal dogs. Am. J. Physiol., 154, 27-38.
2. Amundsen, E., Putter, J., Friberger, P., Knos, M., Larsbraten, M. & Claeson, G. (1979). Methods for the determination of glandular kallikrein by means of a chromogenic tripeptide substrate. Adv. Exp. Med. Biol., 120A: 83-95.
3. Bloechle, C., Kühn, R., Knoefel, W.T., Yekebas, E., Kusterer, K. & Izbicki, J.R. (1994). Bradykinin-antagonist Hoe 140 prevents microcirculatory statis and tissue necrosis in taurocholate induced pancreatitis of the rat. Pancreas, 9, 783.
4. Büchler, M. (1991). Objectification of the severity of acute pancreatitis. Hepatogastroenterology, 38, 101-108.
5. Corfield, A.P., Cooper, M.J. & Williamson, R.C.N. (1985). Acute pancreatitis: A lethal disease of increasing incidence. Gut, 26, 724-729.
6. Evans, D.M., Jones, D.M., Pitt, G.R., Ashworth, D., de Clerck, F., Verheyen, F. & Szelke, M. (1996a). Synthetic inhibitors of human tissue kallikrein. Immunopharmacology, 32, 117-118.
7. Evans, D.M., Jones D.M., Pitt, G.R., Sueiras-Diaz, J., Horton, J., Ashworth, D., Olsson, H. & Szelke, M. (1999b). Selective inhibitors of plasma kallikrein. Immunopharmacology, 32, 115-116.
8. Forrell, M. (1955). Zur frage des entstehungsmechanismus des kreislaufkollapses bein der akuten pankreasnekrose. Gastroenterologia, 84, 225-251.
9. Gamse, R., Holzer, P. & Lembeck, F. (1980). Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin. Br. J. Pharmacol., 68, 207-213.
10. Griesbacher, T., Kolbitsch, C., Tiran, B. & Lembeck, F. (1995). Effects of the bradykinin antagonist, icatibant (Hoe 140), on pancreas and liver functions during and after caeruelin-induced pancreatitis in rats. Naunyn-Schmiedeb. Arch. Pharmacol., 352, 557-564.
11. 2 receptor antagonist FR173657 in models of visceral and cutaneous inflammation. Inflamm. Res., 49, 535-540.
12. Griesbacher, T. & Lembeck, F. (1992). Effects of the bradykinin antagonist, HOE 140, in experimental acute pancreatitis. Br. J. Pharmacol., 107, 356-360.
13. Griesbacher, T., Tiran, B. & Lembeck, F. (1993). Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoe 140. Br. J. Pharmacol., 108, 405-411.
14. Haberland, G. & McConn, R. (1979). A rationale for the therapeutic action of aprotinin. Fed. Proc., 38, 2760-2767.
15. 2 receptor suppresses acute pancreatitis induced by obstruction of the biliopancreatic duct in rats. Br. J. Pharmacol., 135, 29-36.
16. Hoffmann, T.F., Waldner, H. & Messmer, K. (1996). The bradykinin antagonist CP-0597 can limit the progression of postischemic pancreatitis. Immunopharmacology, 33, 243-246.
17. Ito, R. & Statland, B.E. (1981). Centrifugal analysis for plasma kallikrein activity, with use of the chromogenic substrate S-2302. Clin. Chem., 27, 586-593.
18. Lampel, M. & Kern, H.F. (1977). Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue. Virchows Arch. (Pathol. Anat.), 373, 97-117.
19. Lerch, M.M., Weidenbach, H., Gress, T. & Adler, G. (1995). Effect of kinin inhibition in experimental acute pancreatitis. Am. J. Physiol., 269, G490-G499.
20. Prado, J.L. (1970). Proteolytic enzymes as kininogenases. Handb. Exp. Pharmacol., 25, 156-192.
21. Saluja, A.K., Hashimoto, S., Saluja, M., Powers, R.E., Meldolesi, J. & Steer, M.L. (1987). Subcellular redistribution of lysosomal enzymes during caerulein-induced pancreatitis. Am. J. Physiol., 253, G508-G516.
22. Saria, A. & Lundberg, J.M. (1983). Evans blue fluorescence: Quantitative and morphological evaluation of vascular permeability in animal tissues. J. Neurosci. Meth., 8, 41-49.
23. Satake, K., Ha, H.H. & Hiura, A. (1996). Effects of bradykinin receptor antagonist on the release of beta-endorphin and bradykinin and on hemodynamic changes in a canine model of experimental acute pancreatitis. Pancreas, 12, 92-97.
24. Shori, D.K., Procter, G.B., Chao, J., Chan, K.M. & Garrett, J.R. (1992). New specific assays for tonin and tissue kallikrein activities in rat submandibular glands. Assays reveal differences in the effects of sympathetic and parasympathetic stimulation on proteinases in saliva. Biochem. Pharmacol., 43, 1209-1217.
25. Siegel, S. & Castellan JR, N.J. (1988). Nonparametric Statistics for the Behavioral Sciences 2nd Ed. New York: McGraw-Hill.
26. Uehara, S., Honjyo, K., Furukawa, S., Hirayama, A. & Sakamoto, W. (1989). Role of the kallikrein-kinin system in human pancreatitis. Adv. Exp. Med. Biol., 247B, 157-162.
27. Werle, E., Tauber, K, Hartenbach, W. & Forrell, M.M. (1958). Zur frage der therapie der pankreatitis. Münch. Med. Wochenschr., 100, 1265-1267.
28. Willemer, S., Bialek, L. & Adler, G. (1990). Localization of lysosomal and digestive enzymes in cytoplasmic vacuoles in caerulein-pancreatitis. Histochemistry, 94, 161-170.
29. Willemer, S., Elsässer, H.-P. & Adler, G. (1992). Hormone-induced pancreatitis. Eur. Surg. Res., 24 (Suppl. 1): S29-S39.
30. Wilson, C. & Imrie, C.W. (1990). Changing patterns of incidence and mortality from acute pancreatitis in Scotland, 1961-1985. Br. J. Surg., 77, 731-734.
31. Zar, J.H. (1984). Biostatistical Analysis. 2nd Ed. Englewood Cliffs, N.J.: Prentice-Hall.